Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M13,294,919,482Revenue $M--Net Margin (%)--Altman Z-Score
Enterprise Value $M13,294,919,482EPS $--Operating Margin %--Piotroski F-Score--
P/E(ttm)20.9Beneish M-Score--Pre-tax Margin (%)--Higher ROA y-yN
Price/Book--10-y EBITDA Growth Rate %--Quick Ratio--Cash flow > EarningsN
Price/Sales--5-y EBITDA Growth Rate %--Current Ratio--Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)--Higher Current Ratio y-yN
Dividend Yield %1.6PEG--ROE % (ttm)--Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M100,000,000ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with XLV

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
XLVKen Fisher 2015-12-31 Add$66.86 - $72.99
($70.76)
$ 63.52-10%Add 2.64%293,541
XLVKen Fisher 2015-09-30 Add$64.29 - $77.22
($73.06)
$ 63.52-13%Add 5.33%285,985
XLVLeon Cooperman 2015-06-30 Sold Out -0.42%$71.46 - $76.45
($73.85)
$ 63.52-14%Sold Out0
XLVKen Fisher 2015-06-30 Add$71.71 - $76.45
($74.07)
$ 63.52-14%Add 5.40%271,515
XLVLeon Cooperman 2015-03-31 Buy 0.42%$67.86 - $74.9
($71.15)
$ 63.52-11%New holding366,000
XLVKen Fisher 2015-03-31 Add$68.05 - $74.9
($71.32)
$ 63.52-11%Add 4.15%257,614
XLVKen Fisher 2014-06-30 Add0.01%$55.71 - $61.23
($58.7)
$ 63.528%Add 34.36%226,412
XLVGeorge Soros 2012-09-30 Sold Out -0.03%$37.27 - $40.3
($38.73)
$ 63.5264%Sold Out0
XLVGeorge Soros 2012-06-30 Buy 0.03%$35.52 - $37.87
($36.91)
$ 63.5272%New holding50,000
XLVKen Fisher 2012-06-30 Add$35.52 - $37.87
($36.91)
$ 63.5272%Add 53.52%119,754
XLVKen Fisher 2011-06-30 Buy 0.01%$33.28 - $36.42
($34.99)
$ 63.5282%New holding86,997
XLVGeorge Soros 2011-03-31 Sold Out $31.5 - $33.18
($32.33)
$ 63.5296%Sold Out0
XLVGeorge Soros 2010-12-31 Reduce-0.15%$30.19 - $31.78
($31.13)
$ 63.52104%Reduce -93.88%34,153
XLVGeorge Soros 2010-09-30 Buy 0.25%$28.03 - $30.68
($29.2)
$ 63.52118%New holding558,053
XLVGeorge Soros 2010-06-30 Sold Out $28.38 - $32.31
($30.13)
$ 63.52111%Sold Out0
XLVGeorge Soros 2010-03-31 Reduce$30.68 - $33
($31.72)
$ 63.52100%Reduce -43.59%6,600
XLVGeorge Soros 2009-12-31 Buy 0.01%$28.07 - $31.62
($30.04)
$ 63.52111%New holding11,700
XLVBill Gates 2009-06-30 Sold Out -4.19%$23.76 - $26.53
($25.04)
$ 63.52154%Sold Out0
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

XLV is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


XLV: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
MCCREADIE, KEVIN ANDREWSenior Officer 2016-02-11Buy5,000$4.361356.88view
Loutitt, Sandy Luke10% Security Holder, Director 2016-02-11Buy1,000$9.35579.36view
Cheng, DanielSenior Officer 2016-02-11Buy1,000$27.01135.17view
Isenberg, RobertDirector or Senior Officer of Insider or Subsidiar 2016-02-11Buy400$27135.26view
Hurtubise, Roger BradleyDirector 2016-02-11Buy3,100$10.25519.71view
Sierra Wireless, Inc.Issuer 2016-02-11Buy70,000$10.05532.04view
Monahan, Gregory RushDirector 2016-02-11Buy2,000$5.95967.56view
EVANS, ROBERT ANTHONYDirector 2016-02-11Sell5,000$1.175329.06view
McNaughton, Kenneth C.10% Security Holder 2016-02-11Buy30,000$0.163420view
Kovacevic, John GianniDirector, Senior Officer 2016-02-11Buy88,000$0.03211633.33view

Quarterly/Annual Reports about XLV:

    News about XLV:

    Articles On GuruFocus.com
    S&P 500 Sector ETFs: A Look Under the Hood, Part 3 Mar 11 2015 
    Build a “Whatever Happens” Portfolio – Now! Aug 15 2014 
    Are Earnings Important? These Days, Revenues Count for More! Mar 17 2014 

    More From Other Websites
    Analyzing the Future Estimates for Eli Lilly and Co. Feb 11 2016
    MDT’s Earnings Are Expected to Continue to Grow in Fiscal 3Q16 Feb 11 2016
    Cigna’s Diversification Strategy Boosts Its 4Q15 Earnings Feb 09 2016
    What You Need to Know about the Abbott Labs Side of the Alere-Abbott Merger Feb 09 2016
    The Alere-Abbott Labs Merger: Understanding the Alere Side Feb 09 2016
    What Investors Can Expect from Healthcare Sector Companies Feb 09 2016
    Eli Lilly and Co.’s 4Q15: Profitability and Financial Guidance Feb 09 2016
    Monday links: sickening stocks Feb 08 2016
    Major Developments for Eli Lilly and Co. in 4Q15 Feb 08 2016
    Elanco’s 4Q15 Performance: Eli Lilly’s Animal Health Segment Feb 08 2016
    Solid Volume Growth Drove HCA Holdings’s Revenue in 4Q15 Feb 08 2016
    Perrigo’s Shareholders Rejected Mylan’s Offer on Value Dilution Feb 08 2016
    Trends driving deal flow Feb 08 2016
    Fasten Your Seatbelts: More Craziness in the Week Ahead Feb 07 2016
    Aetna Posted Higher-than-Expected Earnings per Share in 4Q15 Feb 04 2016
    Rationale for the Alere–Abbott Laboratories Merger Feb 04 2016
    Abbott Labs Beefs Up Its Diagnostics Portfolio with Alere Feb 04 2016
    Parsing the Baxalta–Shire Material Adverse Effect Clause, Part 2 Feb 01 2016
    Analysts Expect MDT’s Fiscal 3Q16 Revenues to be $6.9 Million Feb 01 2016
    Strong Revenue for Abbott Point of Care Diagnostics Division Feb 01 2016

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    FEEDBACK